Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness.
- Published in:
- Hematology in Clinical Practice, 2022, v. 13, n. 3/4, p. 130, doi. 10.5603/HCP.a2022.0015
- By:
- Publication type:
- Article
Works matching IS 27201015 AND DT 2022 AND VI 13 AND IP 3/4
Results: 6
1
2
Plasmablastic lymphoma in an HIV-negative patient with complete remission after chemotherapy with DA-EPOCH.
- Published in:
- Hematology in Clinical Practice, 2022, v. 13, n. 3/4, p. 123, doi. 10.5603/HCP.a2022.0016
- By:
- Publication type:
- Article
3
Therapeutic options in high-risk myelodysplastic syndrome.
- Published in:
- Hematology in Clinical Practice, 2022, v. 13, n. 3/4, p. 97, doi. 10.5603/HCP.a2022.0017
- By:
- Publication type:
- Article
4
Practical aspects of the use of ventoclax in combination with azacitidine for the treatment of newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy.
- Published in:
- Hematology in Clinical Practice, 2022, v. 13, n. 3/4, p. 112, doi. 10.5603/HCP.a2022.0018
- By:
- Publication type:
- Article
5
Waldenström macroglobulinemia: diagnosis and treatment.
- Published in:
- Hematology in Clinical Practice, 2022, v. 13, n. 3/4, p. 89, doi. 10.5603/HCP.a2022.0014
- By:
- Publication type:
- Article
6
Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients.
- Published in:
- Hematology in Clinical Practice, 2022, v. 13, n. 3/4, p. 81, doi. 10.5603/HCP.a2022.0012
- By:
- Publication type:
- Article